Sfoglia per Autore
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene
2006-01-01 Coscia M; Quaglino E; Pantaleoni F; Curcio C; Boccadoro M; Forni G; Massaia M
Effective anti-tumor immunomodulatory properties of zoledronic acid
2007-01-01 Coscia M; Quaglino E; Pantaleoni F; Curcio C; Rigoni M; Forni G; Massaia M
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia
2007-01-01 Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells
2007-01-01 Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL)
2008-01-01 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES
2009-01-01 M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2009-01-01 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT
2009-01-01 Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
2010-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
2010-01-01 Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status.
2010-01-01 Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS
2011-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells
2011-01-01 Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
2011-01-01 Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)
2012-01-01 Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome
2017-01-01 Pannone, Luca; Bocchinfuso, Gianfranco; Flex, Elisabetta; Rossi, Cesare; Baldassarre, Giuseppina; Lissewski, Christina; Pantaleoni, Francesca; Consoli, Federica; Lepri, Francesca; Magliozzi, Monia; Anselmi, Massimiliano; Delle Vigne, Silvia; Sorge, Giovanni; Karaer, Kadri; Cuturilo, Goran; Sartorio, Alessandro; Tinschert, Sigrid; Accadia, Maria; Digilio, Maria C.; Zampino, Giuseppe; De Luca, Alessandro; Cavé, Hélène; Zenker, Martin; Gelb, Bruce D.; Dallapiccola, Bruno; Stella, Lorenzo; Ferrero, Giovanni B.; Martinelli, Simone; Tartaglia, Marco
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 2004 | Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M | |
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene | 2006 | Coscia M; Quaglino E; Pantaleoni F; Curcio C; Boccadoro M; Forni G; Massaia M | |
Effective anti-tumor immunomodulatory properties of zoledronic acid | 2007 | Coscia M; Quaglino E; Pantaleoni F; Curcio C; Rigoni M; Forni G; Massaia M | |
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia | 2007 | Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M | |
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells | 2007 | Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia | |
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) | 2008 | M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia | |
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES | 2009 | M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia | |
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2009 | Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M. | |
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT | 2009 | Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M. | |
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals | 2010 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway | 2010 | Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M | |
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. | 2010 | Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia | |
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS | 2011 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells | 2011 | Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M | |
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells | 2011 | Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M | |
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) | 2012 | Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome | 2017 | Pannone, Luca; Bocchinfuso, Gianfranco; Flex, Elisabetta; Rossi, Cesare; Baldassarre, Giuseppina; Lissewski, Christina; Pantaleoni, Francesca; Consoli, Federica; Lepri, Francesca; Magliozzi, Monia; Anselmi, Massimiliano; Delle Vigne, Silvia; Sorge, Giovanni; Karaer, Kadri; Cuturilo, Goran; Sartorio, Alessandro; Tinschert, Sigrid; Accadia, Maria; Digilio, Maria C.; Zampino, Giuseppe; De Luca, Alessandro; Cavé, Hélène; Zenker, Martin; Gelb, Bruce D.; Dallapiccola, Bruno; Stella, Lorenzo; Ferrero, Giovanni B.; Martinelli, Simone; Tartaglia, Marco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile